Joseph Pastore, PhD
Senior Vice President, Clinical Product Development Juventas Therapeutics
Joseph Pastore, Ph.D. oversaw manufacturing, preclinical, and clinical development. He led the team that has translated Juventas’ lead product, JVS-100, from concept through Phase II trials. He was responsible for development and implementation of clinical/regulatory strategy, internal staffing and outsourcing of clinical operations, and leading interactions with the FDA which includes the approval of multiple Investigational New Drug (IND) submissions. Previous to Juventas, he worked with Guidant Corporation (acquired by Boston Scientific) where he was responsible for translating novel cardiac therapies from concept to clinic. He managed pre-clinical, first-in-man, and Phase II clinical trials, and worked cross-functionally with business development, marketing, reimbursement, and regulatory teams to build and execute development strategies for early stage products. He received his Ph.D. in Biomedical Engineering from Case Western Reserve University.
Joe passed away January 27, 2018 after a courageous battle against cancer.
End of main page content.